RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $110,000 | -2.7% | 39,500 | 0.0% | 0.00% | – |
| Q4 2020 | $113,000 | +27.0% | 39,500 | -7.1% | 0.00% | – |
| Q3 2020 | $89,000 | -58.4% | 42,500 | -9.6% | 0.00% | – |
| Q2 2020 | $214,000 | -11.9% | 47,000 | +57.7% | 0.00% | – |
| Q1 2020 | $243,000 | -27.2% | 29,800 | +63.7% | 0.00% | – |
| Q4 2019 | $334,000 | +65.3% | 18,200 | 0.0% | 0.00% | – |
| Q3 2019 | $202,000 | +0.5% | 18,200 | -8.1% | 0.00% | – |
| Q2 2019 | $201,000 | +95.1% | 19,800 | +13.1% | 0.00% | – |
| Q1 2019 | $103,000 | -22.6% | 17,500 | -6.4% | 0.00% | – |
| Q4 2018 | $133,000 | 0.0% | 18,700 | 0.0% | 0.00% | – |
| Q3 2018 | $133,000 | +41.5% | 18,700 | 0.0% | 0.00% | – |
| Q2 2018 | $94,000 | – | 18,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |